LillyDirect — Foundayo review: true cost, trust file, verdict
Manufacturer direct — oral orforglipron (approved Apr 2026) · The distribution channel for the first once-daily GLP-1 pill with no food-and-water choreography. Pricing is aggressive at entry doses ($149–$199 promo tiers through 2026). Same fills-only model and same platform logistics as Zepbound Self Pay.
The fee anatomy
| Medication | Tier | Med / month | True monthly | First month |
|---|---|---|---|---|
| Foundayo (orforglipron) pill | 0.8 mg | $149 | $149 | $149 |
| Foundayo (orforglipron) pill | 2.5 mg | $199 | $199 | $149 |
| Foundayo (orforglipron) pill | 5.5 mg | $299 | $299 | $149 |
| Foundayo (orforglipron) pill | 9 mg | $299 | $299 | $149 |
| Foundayo (orforglipron) pill | 14.5 mg | $349 | $349 | $149 |
| Foundayo (orforglipron) pill | 17.2 mg | $349 | $349 | $149 |
First GLP-1 pill approved under FDA National Priority Voucher (4/1/26). Promo through 12/31/26: 2.5mg at $149, 5.5mg at $199. Top doses require 45-day refill.
The trust file
| LegitScript | not independently verifiable same LillyDirect platform |
| Trustpilot | 1.6 / 5 (94 reviews) platform-level, not Foundayo-specific · source |
| BBB | no profile |
| Operating since | 2026 (Foundayo approved Apr 1, 2026) |
| Prescriber model | fills only — no prescribing |
| Contract | — |
| Refunds & cancellation | — |
Same four dispensing pharmacies as LillyDirect Zepbound.
The verdict: who it's actually for
- You want the newest oral option at manufacturer pricing
- Needle-free matters and Wegovy pill's timing rules annoy you
- You want a prescriber included
- You need established long-term real-world data — this drug launched in April 2026
Compare against every channel on the True-Cost Index, or let the Savings Wizard place this provider in your personal ranking.
Pricing from the provider's published pages on the date shown; trust facts from the linked third-party sources on 2026-09-06. No provider pays for placement or previews this page. Some links may earn commissions; verdicts never bend — disclosure. Not medical advice.